PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 172 (117th)

United States Anti-Doping Agency Reauthorization Act of 2021

referredUnited States· United States Congress· EN

Introduced

4 January 2021

Last action

15 April 2021 · Introduced

Status

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Sponsors

Rep. Thompson, Mike [D-CA-4], Bill Johnson, Diana DeGette

Subjects

Discovery layer

Source updated

5 December 2025

Official sourceDownload fileView documentsShare

Summary

United States Anti-Doping Agency Reauthorization Act of 2021 This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030. The bill adds requirements that USADA be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports. The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection. The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 4 January 2021

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 4 January 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 4 January 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 February 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 14 April 2021

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  6. 14 April 2021

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 172.

    Source: Floor

  7. 14 April 2021

    Floor

    Mr. Pallone moved to suspend the rules and pass the bill.

    Source: Floor

  8. 14 April 2021

    Vote

    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)

    Source: Floor

  9. 14 April 2021

    Vote

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)

    Source: Floor

  10. 14 April 2021

    Floor

    Considered under suspension of the rules. (consideration: CR H1748-1750)

    Source: Floor

  11. 14 April 2021

    Vote

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    Source: Floor

  12. 15 April 2021

    Introduced

    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

    Source: IntroReferral

Votes

14 April 2021 · passed · On Motion to Suspend the Rules and Pass · Passed · Official source

Yes 381 · No 37 · Abstain — · Absent/not voting 11

Showing the first 8 recorded positions. Vote totals above are complete.

Versions

Documents

8 official files

Referred in Senate (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.